Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Ryan J Sullivan

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016.

scientific article published on 8 December 2016

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

article

Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients

scientific article published on 06 June 2019

Author Correction: PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance

scientific article published on 01 November 2019

Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma

scientific article published in 2022

Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

scientific article published on 01 November 2018

Evolution of delayed resistance to immunotherapy in a melanoma responder

scientific article published on 03 May 2021

Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastases

scientific article published on 12 October 2021

PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance

scientific article published on 29 July 2019

Pathway signatures derived from on-treatment tumor specimens predict response to anti-PD1 blockade in metastatic melanoma

scientific article published on 15 October 2021

Plasma-derived extracellular vesicle analysis and deconvolution enable prediction and tracking of melanoma checkpoint blockade outcome

scientific article published on 13 November 2020

Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis

scientific article published on 18 June 2020

STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming

scientific article published on 06 April 2022

Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis

scientific article published on 01 June 2020

When is it OK to Stop Anti-Programmed Death 1 Receptor (PD-1) Therapy in Metastatic Melanoma?

scientific article published on 05 February 2020

Paulina is supported by:

About Paulina

Help